Ferroptosis inhibitors: latest advances and therapeutic potential for pulmonary arterial hypertension
{{output}}
Pulmonary arterial hypertension (PAH) is a progressive, high-mortality disease with multifactorial pathology. Although current therapies primarily target vascular remodeling, single-pathway approaches often remain insufficient against its complex pathogenesis.... ...
